Cyclin-dependent kinase 2 - Wikipedia
Cdk1: the dominant sibling of Cdk2 | Nature Cell Biology
Frontiers | Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
Phospho-CDK2 (Tyr15) cellular HTRF kit | Cisbio
Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer | Journal of Medicinal Chemistry
A kinetic model of the cyclin E/Cdk2 developmental timer in Xenopus — Physiome Model Repository
The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit: Cell
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma | Molecular Medicine | Full Text
Targeting CDK2 in cancer: challenges and opportunities for therapy - ScienceDirect
Cycling without CDK2?: Trends in Cell Biology
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy | Nature Chemical Biology
Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines | Journal of Medicinal Chemistry
A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation | Science Advances
Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†
A dual role of Cdk2 in DNA damage response | Cell Division | Full Text
CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/ CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point | PLOS Genetics
CDK1 and CDK2 regulate NICD1 turnover and the periodicity of the segmentation clock | EMBO reports
NU6102 is a Potent CDK1 and CDK2 Inhibitor - Network of Cancer Research
A novel landscape of nuclear human CDK2 substrates revealed by in situ phosphorylation | Science Advances
Chemical Genetics Reveals a Specific Requirement for Cdk2 Activity in the DNA Damage Response and Identifies Nbs1 as a Cdk2 Substrate in Human Cells | PLOS Genetics
NU6140 is a Highly Selective Cyclin-Dependent Kinase 2 (Cdk2) Inhibitor - Network of Cancer Research
CDK2 Antibody (E8J9T) | Cell Signaling Technology
Cdk2 and Cdk4 Regulate the Centrosome Cycle and Are Critical Mediators of Centrosome Amplification in p53-Null Cells | Molecular and Cellular Biology
Cdk2: a key regulator of the senescence control function of Myc | Aging
